Page last updated: 2024-10-26

doxazosin and Leukoencephalopathy Syndrome, Posterior

doxazosin has been researched along with Leukoencephalopathy Syndrome, Posterior in 2 studies

Doxazosin: A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
doxazosin : A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.

Research Excerpts

ExcerptRelevanceReference
"Typical posterior reversible encephalopathy syndrome (PRES) is a clinical-neuroradiological entity characterised by bilateral white matter oedema, which is usually symmetrical and totally reversible in 2-3 weeks."1.56Tumour-like presentation of atypical posterior reversible encephalopathy syndrome with prominent brainstem involvement. ( De Angelis, MV; Di Stefano, V; Onofrj, M; Rispoli, MG, 2020)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Di Stefano, V1
Rispoli, MG1
Onofrj, M1
De Angelis, MV1
Akın, F1
Kılıçaslan, C1
Solak, ES1
Uzun, M1
Aygün, S1
Arslan, Ş1

Other Studies

2 other studies available for doxazosin and Leukoencephalopathy Syndrome, Posterior

ArticleYear
Tumour-like presentation of atypical posterior reversible encephalopathy syndrome with prominent brainstem involvement.
    BMJ case reports, 2020, Jan-08, Volume: 13, Issue:1

    Topics: Antihypertensive Agents; Brain Stem; Calcium Channel Blockers; Diagnosis, Differential; Doxazosin; H

2020
Posterior reversible encephalopathy syndrome in children: report of three cases.
    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2014, Volume: 30, Issue:3

    Topics: Adolescent; Anticonvulsants; Antihypertensive Agents; Brain Stem; Cerebral Cortex; Child; Child, Pre

2014